Edwards Lifesciences Corp

• Country

  United States of America

• Sector

  Health Care

• Industry group

  Health Care Equipment & Services

• Industry

  Health Care Equipment & Supplies

• Sub-sector

  Health Care

• Capitalization (millions of $)

  54341.9

• Ticker

  EW.N

• ISIN

  US28176E1082

• IPO date

  2000-03-27

• Availability on Russian exchanges

  Yes

• Reporting for

  2024-02-12

• Date fact. publication of reports

  2023-12-31

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. Its Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.